Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial.
Wen HY, Wang J, Zhang SX, Luo J, Zhao XC, Zhang C, Wang CH, Hu FY, Zheng XJ, Cheng T, Niu HQ, Liu GY, Yang WX, Yu NN, Ru JL, Chen QX, Lu XC, He PF, Gao C, Li XF.
Wen HY, et al. Among authors: wang j, wang ch.
J Immunol Res. 2019 Nov 3;2019:7684352. doi: 10.1155/2019/7684352. eCollection 2019.
J Immunol Res. 2019.
PMID: 31781682
Free PMC article.
Clinical Trial.